A New Treatment Approach for Cystic Fibrosis
Newswise — Antisense oligonucleotides, or ASOs, are molecules that can be used to control protein levels in cells. Cold Spring Harbor...
Developing CF Care in Egypt
MECFA and Prof Samya Nasr, the CF Director of the Mott CF Center in Michigan have teamed up to host CF allied health workshops to take...
Give Breath. Give Life.
Every day all over the world CF patients use their nebulizers for inhalation therapy that helps them breathe and live healthier....
How MECFA works to improve the lives of CF patients in the Middle East
In today’s article we outline how MECFA works to improve the lives of CF patients in the Middle East through access to better health...
Challenges of Living with Cystic Fibrosis in the Middle East, North Africa, and Central Asia
Orphan drug legislation in the USA and Europe has led to the development and rapid approval of new treatments for rare diseases,...
Middle East CF Association (MECFA): Impact Overview Part 2
In our last blog post, we shared a little about MECFA’s mission, key objectives and principles. In today’s post, we are sharing just...
Middle East CF Association (MECFA): Impact Overview
The mission of the Middle East CF Association (MECFA) is to improve health outcomes and life expectancy of patients with Cystic fibrosis...
Middle East Hospitals Gain Access to Much Needed Cystic Fibrosis Diagnosis and Treatment Resources
Through the MECFA diagnostic pilot program, ten hospitals located throughout the Middle East can now provide early accurate cystic...
Study Will Assess How Diet, Exercise May Extend Lifespan
People with cystic fibrosis (CF) generally are living longer and healthier lives than in the recent past. Now, researchers will conduct a...
Lung Disease Evident in CF Patients in Study Despite ‘Normal’ Lung Function
Signs of lung disease were evident in most cystic fibrosis (CF) patients with normal lung function in a small study, and related with a...
